Dr. Marco Prado
Scientist, Robarts Research Institute
Professor, University of Western Ontario
Marco Prado obtained his Pharmacy degree at the Federal Fluminense University (Rio de Janeiro, Brazil). He then trained in neurochemistry with Dr. Marcus Vinicius Gomez (Brazil) and Dr. Brian Collier (Canada) and holds a MSc (1989) and a PhD from the Federal University of Minas Gerais (Brazil, 1993) and a second advanced degree from the University of Sao Paulo (Livre-doceasdfncia). He is a scientist at the Robarts Research Institute and a Professor in the Department of Physiology and Pharmacology and Department of Anatomy & Cell Biology, University of Western Ontario, Canada (since 2008). Prior to his recruitment to Robarts, for which he was awarded a Recruitment Grant from PrioNet-Canada, he was an Associate Professor at the Federal University of Minas Gerais (Brazil, 1994-2008). Marco Prado was also a visiting scientist with Dr. Marc Caron at Duke University during a sabbatical period (2003-2004). He served as a section editor in Cell Biology for the Brazilian Journal of Medical and Biological Research (2003-2008) and currently serves in the Editorial Board of Journal of Neurochemistry as a handling editor. Marco Prado received multiple junior (1994-2000) and then senior (2000-2008) competitive fellowships from the National Science Foundation (CNPq-Brazil). He also received a fellowship from IBRO (2003) and was selected as a Guggenheim fellow by the John Simon Guggenheim Memorial Foundation (2004-2005). In 2013 he received a Faculty Scholar Award from the University of Western Ontario. He has held grants from the NIH (USA), American Health Assistant Foundation (USA), PrioNet-Canada (Canada), CNPq, FINEP and FAPEMIG (Brazil).
His laboratory at the University of Western Ontario is currently funded by the Canadian Institutes of Health Research, The Heart and Stroke Foundation of Ontario, Canadian Foundation for Innovation, Ontario Research Fund and The Alzheimer’s Association (USA). Dr. Prado has generated novel genetically-modified mice to model neurochemical deficits in dementia, with particular focus on Alzheimer’s disease. One of the major interests of Dr. Prado is to develop new approaches to improve outcomes in Alzheimer’s disease and related dementia. Other interests in the Prado laboratory span mechanisms of disease in prion diseases, stroke and heart failure. He has deposited 3 patents, trained over 30 graduate students and post-doctoral fellows and published over 120 manuscripts in journals such as Neuron, PLoS Biology, PNAS, J. Neuroscience and FASEB J.